Non-Communicable Diseases Part 2 Measures taken to reduce NCDs in India: National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS): The Department of Health & Family Welfare, provides technical and financial support to the States/UTs under NPCDCS, as part of […]
Alleviating the scourge of private healthcare #GS-02 Healthcare For Prelims Healthcare Expenditure in India: India’s public health expenditure as a percentage of its GDP is 1.28%. While its share of general government expenditure dedicated to health remains 8%. Due to these parameters private spending still […]
PIB Analysis 24-12-22 – Part 2 Promotion of Digital Literacy India over the last 7 years has become a prominent nation in deploying technologies for the benefit and transforming the lives of its citizens. Keeping this in view, the Government is focusing on providing digital […]
PIB Analysis 24-12-22 – Part 1 Startup India Seed Fund Scheme (SISFS) The Startup India Seed Fund Scheme (SISFS) implemented with effect from 1st April 2021. The Scheme aims to provide financial assistance to startups for proof of concept, prototype development, product trials, market entry […]
Centrally Protected Monuments #GS-01 Indian Culture and Heritage For Prelims Centrally protected monuments in India: India has a total of 3,695 Centrally Protected Monuments or Sites at present with UP having the highest number at 743. Centrally Protected Monuments are protected by Archaeological Survey of […]
Defence Research and Development Organisation (DRDO) #GS-03 Science and Technology For Prelims: DRDO: The Defence Research and Development Organisation works under the administrative control of Ministry of Defence, Government of India. DRDO has been created as the Research and Development wing of the Ministry of […]
iNCOVACC #GS-03 Science and Technology, #GS-02 Healthcare For Prelims iNCOVACC iNCOVACC is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington University School of Medicine. Codenamed BBV154, it had received permission for restricted use in November. The nasal […]
